Land: Irland
Språk: engelska
Källa: HPRA (Health Products Regulatory Authority)
SALMETEROL XINAFOATE
PCO Manufacturing
R03AC12
SALMETEROL XINAFOATE
25 Mcg/Acutuation
Pressurised Inhalation Suspension
Product subject to prescription which may be renewed (B)
Selective beta-2-adrenoreceptor agonists
Authorised
2011-04-15
_ _ PACKAGE LEAFLET: INFORMATION FOR THE USER SEREVENT ® EVOHALER ® 25 MICROGRAMS PER ACTUATION (PER PUFF) PRESSURISED INHALATION, SUSPENSION salmeterol READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. – Keep this leaflet. You may need to read it again. – If you have any further questions, ask your doctor or pharmacist. – This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. – If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. IN THIS LEAFLET: 1. What Serevent Evohaler is and what it is used for 2. What you need to know before you use Serevent Evohaler 3. How to use Serevent Evohaler 4. Possible side effects 5. How to store Serevent Evohaler 6. Contents of the pack and other information 1. WHAT SEREVENT EVOHALER IS AND WHAT IT IS USED FOR Serevent Evohaler contains the medici ne salmeterol. It is a ‘long-acting bronchodilator’. It helps the airways in the lungs to stay open. This makes it easier for air to get in and out. The effects are usually felt within 10 to 20 minutes and last for 12 hours or more. The doctor has prescribed it to help prevent breathing problems. These could be caused by asthma. Taking Serevent Evohaler regularly will help prevent asthma attacks. This also includes asthma brought on by exercise or that happens only at night. Taking Serevent Evohaler regularly will also help prevent breathing problems caused by other chest illnesses such as chronic obstructive pulmonary di Läs hela dokumentet
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Serevent Evohaler 25 micrograms per actuation pressurised inhalation suspension 2 QUALITATIVE AND QUANTITATIVE COMPOSITION One metered dose (ex-valve) contains 25 micrograms salmeterol (as xinafoate). This is equivalent to a delivered dose (ex-actuator) of 2l micrograms salmeterol (as xinafoate). For a full list of excipients, see section 6.1 3 PHARMACEUTICAL FORM Pressurised inhalation, suspension _Product imported from Hungary and Portugal:_ White to off white suspension sealed in an aluminium canister in a green actuator 4 CLINICAL PARTICULARS As per PA1077/047/005 5 PHARMACOLOGICAL PROPERTIES As per PA1077/047/005 6 PHARMACEUTICAL PARTICULARS 6.1 LIST OF EXCIPIENTS Norflurane (HFA 134a), a hydrofluoroalkane (non-chlorofluorocarbon) propellant 6.2 INCOMPATIBILITIES Not applicable HEALTH PRODUCTS REGULATORY AUTHORITY ________________________________________________________________________________________________________________________ _Date Printed 13/11/2014_ _CRN 2146388_ _page number: 1_ 6.3 SHELF LIFE The shelf-life expiry date of this product shall be the date shown on the container and outer package of the product on the market in the country of origin. 6.4 SPECIAL PRECAUTIONS FOR STORAGE Replace the mouthpiece cover firmly and snap it into position. Do not store above 30°C. Pressurised container. Do not expose to temperatures higher than 50°C. Do not puncture, break or burn even when apparently empty. 6.5 NATURE AND CONTENTS OF CONTAINER The suspension is contained in an internally lacquered, 8ml aluminium alloy pressurised container sealed with a metering valve. The containers are fitted into plastic actuators incorporating an atomising mouthpiece and fitted with dustcaps. One pressurised container delivers 120 actuations. 6.6 SPECIAL PRE Läs hela dokumentet